Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictability of Bleeding in Patients Taking Warfarin Using Self-Organizing Map and Multilayer Perceptron Neural Network
TCTR20180224001Phase 4Recruiting
- Sponsor
- Faculty of Pharmacy, Silpakorn University
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of warfarin, sponsored by Faculty of Pharmacy, Silpakorn University. Primary endpoint: Predictive accuracy of bleeding risk model. Started Mar 2018; status: recruiting.
02
Drugs
warfarin
Beyond the preview
Go deeper on TCTR20180224001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180224001.